User login
Rafael Santana-Davila, MD, discusses how understanding the treatment of non-small cell lung cancer (NSCLC) will help physicians better serve the veteran population.
"NSCLC is the second most common cancer—second to prostate cancer—in the VA and, more importantly, the most common cause of cancer death in our veterans." Santana-Davila said during his 2013 AVAHO meeting presentation. "The main goal of the treatment is to improve quality of life and extend survival as much as possible."
Rafael Santana-Davila, MD, discusses how understanding the treatment of non-small cell lung cancer (NSCLC) will help physicians better serve the veteran population.
"NSCLC is the second most common cancer—second to prostate cancer—in the VA and, more importantly, the most common cause of cancer death in our veterans." Santana-Davila said during his 2013 AVAHO meeting presentation. "The main goal of the treatment is to improve quality of life and extend survival as much as possible."
Rafael Santana-Davila, MD, discusses how understanding the treatment of non-small cell lung cancer (NSCLC) will help physicians better serve the veteran population.
"NSCLC is the second most common cancer—second to prostate cancer—in the VA and, more importantly, the most common cause of cancer death in our veterans." Santana-Davila said during his 2013 AVAHO meeting presentation. "The main goal of the treatment is to improve quality of life and extend survival as much as possible."